GlassScriptPhysician profile
James Charles Knoer
NPI 1720027063
$2,319.36
in general payments reported to CMS, 2019-2025
32 companies · $588 in 2025
The $588 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2020: $87.44 · 2021: $197 · 2022: $528 · 2023: $347 · 2024: $274 · 2025: $588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,208.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $287.94 | 2019-2023 | |
| Astellas Pharma US INC | $252.60 | 2019-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $182.38 | 2022-2025 | |
| Channel Medsystems, INC. | $164.08 | 2022 | |
| Minerva Surgical, INC | $113.90 | 2025 | |
| Millicent US INC | $109.04 | 2019-2025 | Femlyv, Intrarosa |
| Pfizer INC. | $104.01 | 2020-2024 | |
| Therapeuticsmd, INC. | $103.94 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $99.67 | 2019-2025 | |
| Hologic Sales and Service, LLC | $88.22 | 2020-2025 | Thinprep 2000 Processor, Aptima |
| Agile Therapeutics, INC. | $77.74 | 2021-2024 | Twirla |
| Evofem Biosciences, INC. | $67.97 | 2022-2025 | Solosec, Phexx, Phexxi |
| Exeltis, USA INC. | $64.89 | 2021-2025 | Slynd |
| Coopersurgical, INC. | $58.69 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Aspira Women'S Health INC | $58.01 | 2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $57.11 | 2023 | Biodfactor, Medihoney, Biofix |
| Allergan, INC. | $50.85 | 2019 | |
| Merck Sharp & Dohme LLC | $44.65 | 2021-2025 | Gardasil 9, Gardasil |
| Meditrina | $43.54 | 2022-2024 | |
| Lsi Solutions INC | $40.46 | 2023-2025 | Fornisee |
| Sumitomo Pharma America, INC. | $39.05 | 2023-2024 | Myfembree |
| Amag Pharmaceuticals, INC. | $23.61 | 2020 | |
| Duchesnay USA Incorporated | $23.03 | 2019 | |
| Biogen, INC. | $22.48 | 2025 | Zurzuvae |
| Shield Therapeutics INC | $22.43 | 2023 | Accrufer |
| Organon LLC | $22.26 | 2024 | |
| Medtronic, INC. | $18.39 | 2025 | Interstim |
| Exact Sciences Corporation | $17.86 | 2025 | The Cologuard Plus Collection Kit |
| Ascend Therapeutics US, LLC | $16.97 | 2024 | |
| Solventum Corporation | $15.80 | 2025 | Prevena |
| Hydrofera LLC | $14.59 | 2025 | Hydrofera Blue Ready - Border |
| Teva Pharmaceuticals USA, INC. | $13.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Knoer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.